StARD10 inhibitors belong to a specialized class of chemical compounds designed to target and modulate the activity of the StARD10 protein. StARD10, or StAR-related lipid transfer domain-containing 10, is an intracellular protein primarily involved in lipid metabolism and transport within cells. Specifically, it plays a crucial role in the transfer of lipids, such as cholesterol and other sterols, between cellular compartments and membranes. StARD10 inhibitors are designed to interact with StARD10, either by directly binding to it or by interfering with its functional mechanisms, with the goal of regulating specific cellular processes related to lipid handling and intracellular lipid transport.
The development and study of StARD10 inhibitors are rooted in the growing understanding of StARD10's significance in lipid homeostasis and cellular physiology. By modulating the activity of StARD10, these inhibitors have the potential to impact various aspects of intracellular lipid trafficking, membrane composition, and lipid-related signaling pathways. This modulation could have wide-ranging effects on cellular functions, including lipid storage, membrane structure, and lipid-mediated signaling cascades. Researchers in this field are continually exploring novel chemical compounds and approaches to fine-tune StARD10 inhibition, with the aim of unraveling the intricate mechanisms underlying lipid metabolism and cellular lipid homeostasis. Understanding the role of StARD10 inhibitors can provide valuable insights into lipid-related processes in diverse biological contexts.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Lipase Inhibitor, THL | 96829-58-2 | sc-203108 | 50 mg | $52.00 | 7 | |
Orlistat inhibits gastric and pancreatic lipases, which might indirectly affect lipid transporters or proteins in lipid metabolism. | ||||||
Nicotinic Acid | 59-67-6 | sc-205768 sc-205768A | 250 g 500 g | $62.00 $124.00 | 1 | |
Niacin (Vitamin B3) affects lipid metabolism, potentially influencing lipid transporters and associated proteins. | ||||||
Probucol | 23288-49-5 | sc-203666 sc-203666A | 100 mg 1 g | $79.00 $166.00 | 5 | |
An antioxidant that also affects cholesterol transport and might indirectly affect lipid-transporting proteins. | ||||||
Ezetimibe | 163222-33-1 | sc-205690 sc-205690A | 25 mg 100 mg | $96.00 $241.00 | 12 | |
Specifically targets intestinal cholesterol absorption which could influence lipid transporters in the intestine. | ||||||
Gemfibrozil | 25812-30-0 | sc-204764 sc-204764A | 5 g 25 g | $66.00 $267.00 | 2 | |
A fibrate drug that lowers lipid levels and might affect lipid transporters or associated proteins. | ||||||
Atorvastatin | 134523-00-5 | sc-337542A sc-337542 | 50 mg 100 mg | $257.00 $505.00 | 9 | |
A statin that inhibits HMG-CoA reductase, potentially influencing downstream lipid transporters. | ||||||
Clofibrate | 637-07-0 | sc-200721 | 1 g | $33.00 | ||
Another fibrate drug affecting lipid metabolism which could influence lipid transporters. | ||||||
CHOLESTYRAMINE RESIN | 11041-12-6 | sc-507509 | 5 g | $210.00 | ||
A bile acid sequestrant that affects lipid metabolism and might indirectly influence lipid transporters. | ||||||